Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas. Obstet Gynecol. 2020 06; 135(6):1313-1326.
View in:
PubMed
subject areas
Adult
Bone Density
Double-Blind Method
Drug Therapy, Combination
Estradiol
Female
Gonadotropin-Releasing Hormone
Headache
Hot Flashes
Humans
Hydrocarbons, Fluorinated
Leiomyoma
Menorrhagia
Middle Aged
Nausea
Norethindrone
Pyrimidines
Quality of Life
Uterine Neoplasms
authors with profiles
Ayman Al-Hendy